Trump administration moves to increase early-stage clinical trials in boost to drugmakers

The Trump administration is launching a new effort to bolster domestic clinical trials for new pharmaceutical products after a year of tumult at the federal health agencies that has slowed down new product approvals and frustrated drugmakers.

Health and Human Services Secretary Robert F.

Kennedy Jr. said in a press release that the project, called […] ...